Clinical trial

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being…

NCT00108862 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other · Completed

Key facts

NCT number NCT00108862
Title Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
Official title A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Acronym STRIDE
Lead sponsor Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other
Collaborators National Institute of Allergy and Infectious Diseases (NIAID) NIH
Status Completed
Phase Phase 4
Study type Interventional
Conditions HIV Infection, Tuberculosis
Intervention type Other
Interventions Strategy: Immediate ART, Strategy: Deferred ART
Enrollment 809
Start date Aug 1, 2006
Primary completion Jul 1, 2010
Completion Jul 1, 2010
First posted Apr 20, 2005
Last update posted Oct 11, 2018
Countries Botswana, Brazil, Haiti, India, Kenya, Malawi, Peru, South Africa, Thailand, Uganda, United States, Zambia and 1 more

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies